Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Plus Therapeutics (PSTV) Return on Assets (2016 - 2025)

Plus Therapeutics has reported Return on Assets over the past 15 years, most recently at 0.01% for Q4 2025.

  • Quarterly Return on Assets rose 1.0% to 0.01% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.01% through Dec 2025, up 1.0% year-over-year, with the annual reading at 0.01% for FY2025, 0.0% changed from the prior year.
  • Return on Assets was 0.01% for Q4 2025 at Plus Therapeutics, up from 0.01% in the prior quarter.
  • Over five years, Return on Assets peaked at 0.0% in Q4 2021 and troughed at 0.02% in Q4 2024.
  • The 5-year median for Return on Assets is 0.01% (2023), against an average of 0.01%.
  • Year-over-year, Return on Assets rose 1bps in 2021 and then decreased -1bps in 2023.
  • A 5-year view of Return on Assets shows it stood at 0.0% in 2021, then tumbled by -118bps to 0.01% in 2022, then dropped by -25bps to 0.01% in 2023, then plummeted by -99bps to 0.02% in 2024, then soared by 58bps to 0.01% in 2025.
  • Per Business Quant, the three most recent readings for PSTV's Return on Assets are 0.01% (Q4 2025), 0.01% (Q3 2025), and 0.01% (Q2 2025).